These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32798595)

  • 1. The declining role of post-treatment neck dissection in human papillomavirus-associated oropharyngeal cancer.
    Daniels CP; Liu HY; Bernard A; Williams C; Foote MC; Ladwa R; McGrath M; Panizza BJ; Porceddu SV
    Radiother Oncol; 2020 Oct; 151():242-248. PubMed ID: 32798595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of a repeat PET/CT scan in HPV-associated Oropharyngeal Cancer following incomplete nodal response from (chemo)radiotherapy.
    Liu HY; Milne R; Lock G; Panizza BJ; Bernard A; Foote M; McGrath M; Brown E; Gandhi M; Porceddu SV
    Oral Oncol; 2019 Jan; 88():153-159. PubMed ID: 30616786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mid-treatment Fluorodeoxyglucose Positron Emission Tomography in Human Papillomavirus-related Oropharyngeal Squamous Cell Carcinoma Treated with Primary Radiotherapy: Nodal Metabolic Response Rate can Predict Treatment Outcomes.
    Lin P; Min M; Lai K; Lee M; Holloway L; Xuan W; Bray V; Fowler A; Lee CS; Yong J
    Clin Oncol (R Coll Radiol); 2021 Dec; 33(12):e586-e598. PubMed ID: 34373179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.
    Garden AS; Gunn GB; Hessel A; Beadle BM; Ahmed S; El-Naggar AK; Fuller CD; Byers LA; Phan J; Frank SJ; Morrison WH; Kies MS; Rosenthal DI; Sturgis EM
    Cancer; 2014 Oct; 120(19):3082-8. PubMed ID: 24898672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection.
    Zhou S; Chan C; Rulach R; Dyab H; Hendry F; Maxfield C; Dempsey MF; James A; Grose D; Lamb C; Schipani S; Wilson C; Cheng Lau Y; Paterson C
    Oral Oncol; 2022 May; 128():105870. PubMed ID: 35447564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
    Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Substantial Reduction in Elective Radiotherapy Dose and Field in Patients With Human Papillomavirus-Associated Oropharyngeal Carcinoma Treated With Definitive Chemoradiotherapy.
    Tsai CJ; McBride SM; Riaz N; Kang JJ; Spielsinger DJ; Waldenberg T; Gelblum D; Yu Y; Chen LC; Zakeri K; Wong RJ; Dunn L; Pfister DG; Sherman EJ; Lee NY
    JAMA Oncol; 2022 Mar; 8(3):364-372. PubMed ID: 35050342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volumetric
    Chotchutipan T; Rosen BS; Hawkins PG; Lee JY; Saripalli AL; Thakkar D; Eisbruch A; El Naqa I; Mierzwa ML
    Head Neck; 2019 Feb; 41(2):366-373. PubMed ID: 30548704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma.
    Lee N; Schoder H; Beattie B; Lanning R; Riaz N; McBride S; Katabi N; Li D; Yarusi B; Chan S; Mitrani L; Zhang Z; Pfister DG; Sherman E; Baxi S; Boyle J; Morris LG; Ganly I; Wong R; Humm J
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):9-17. PubMed ID: 27511842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
    Liu HY; Daniels CP; Trada Y; Bernard A; You KH; Brown E; Foote M; McGrath M; Ladwa R; Panizza BJ; Porceddu SV
    Head Neck; 2021 May; 43(5):1440-1450. PubMed ID: 33427358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic role of medical comorbidities in surgically treated human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Yin LX; Puccinelli CL; Price DL; Karp EE; Price KA; Ma DJ; Lohse C; Moore EJ; Abel KMV
    Oral Oncol; 2020 Sep; 108():104822. PubMed ID: 32504888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.
    Zenga J; Haughey BH; Jackson RS; Adkins DR; Aranake-Chrisinger J; Bhatt N; Gay HA; Kallogjeri D; Martin EJ; Moore EJ; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    Laryngoscope; 2017 Sep; 127(9):2033-2037. PubMed ID: 28008626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node yield from neck dissection in HPV-associated oropharyngeal cancer.
    Zenga J; Stadler M; Massey B; Campbell B; Shukla M; Awan M; Schultz CJ; Wong S; Jackson RS; Pipkorn P
    Laryngoscope; 2020 Mar; 130(3):666-671. PubMed ID: 31206708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De-intensification of therapy in human papillomavirus associated oropharyngeal cancer: A systematic review of prospective trials.
    Patel RR; Ludmir EB; Augustyn A; Zaorsky NG; Lehrer EJ; Ryali R; Trifiletti DM; Adeberg S; Amini A; Verma V
    Oral Oncol; 2020 Apr; 103():104608. PubMed ID: 32163853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of proposed staging systems for human papillomavirus-related oropharyngeal squamous cell carcinoma.
    Malm IJ; Fan CJ; Yin LX; Li DX; Koch WM; Gourin CG; Pitman KT; Richmon JD; Westra WH; Kang H; Quon H; Eisele DW; Fakhry C
    Cancer; 2017 May; 123(10):1768-1777. PubMed ID: 28055120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the neck after definitive chemoradiation in patients with HPV-associated oropharyngeal cancer: An institutional experience.
    Wotman M; Ghaly M; Massaro L; Tham T; Seetharamu N; Kamdar D; Frank D; Kraus D; Teckie S
    Am J Otolaryngol; 2019; 40(5):684-690. PubMed ID: 31229365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
    Bollig CA; Morris B; Stubbs VC
    Head Neck; 2022 Jul; 44(7):1545-1553. PubMed ID: 35365915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of chemotherapy regimen on treatment outcomes in patients with HPV-associated oropharyngeal cancer with T4 disease treated with definitive concurrent chemoradiation.
    Bhattasali O; Ryoo JJ; Thompson LDR; Abdalla IA; Chen J; Iganej S
    Oral Oncol; 2019 Aug; 95():74-78. PubMed ID: 31345397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.